Krapf R, Vetsch R, Vetsch W, Hulter H N
Department of Medicine, Insel University Hospital, Berne, Switzerland.
J Clin Invest. 1992 Dec;90(6):2456-63. doi: 10.1172/JCI116137.
Chronic metabolic acidosis results in metabolic bone disease, calcium nephrolithiasis, and growth retardation. The pathogenesis of each of these sequelae is poorly understood in humans. We therefore investigated the effects of chronic extrarenal metabolic acidosis on the regulation of 1,25-(OH)2D, parathyroid hormone, calcium, and phosphate metabolism in normal humans. Chronic extrarenal metabolic acidosis was induced by administering two different doses of NH4Cl [2.1 (low dose) and 4.2 (high dose) mmol/kg body wt per d, respectively] to four male volunteers each during metabolic balance conditions. Plasma [HCO3-] decreased by 4.5 +/- 0.4 mmol/liter in the low dose and by 9.1 +/- 0.3 mmol/liter (P < 0.001) in the high dose group. Metabolic acidosis induced renal hypophosphatemia, which strongly correlated with the severity of acidosis (Plasma [PO4] on plasma [HCO3-]; r = 0.721, P < 0.001). Both metabolic clearance and production rates of 1,25-(OH)2D increased in both groups. In the high dose group, the percentage increase in production rate was much greater than the percentage increase in metabolic clearance rate, resulting in a significantly increased serum 1,25-(OH)2D concentration. A strong inverse correlation was observed for serum 1,25-(OH)2D concentration on both plasma [PO4] (r = -0.711, P < 0.001) and plasma [HCO3-] (r = -0.725, P < 0.001). Plasma ionized calcium concentration did not change in either group whereas intact serum parathyroid hormone concentration decreased significantly in the high dose group. In conclusion, metabolic acidosis results in graded increases in serum 1,25-(OH)2D concentration by stimulating its production rate in humans. The increased production rate is explained by acidosis-induced hypophosphatemia/cellular phosphate depletion resulting at least in part from decreased renal tubular phosphate reabsorption. The decreased serum intact parathyroid hormone levels in more severe acidosis may be the consequence of hypophosphatemia and/or increased serum 1,25-(OH)2D concentrations.
慢性代谢性酸中毒会导致代谢性骨病、钙性肾结石和生长发育迟缓。在人类中,这些后遗症各自的发病机制尚不清楚。因此,我们研究了慢性肾外代谢性酸中毒对正常人体内1,25-(OH)₂D、甲状旁腺激素、钙和磷代谢调节的影响。在代谢平衡条件下,分别给四名男性志愿者服用两种不同剂量的氯化铵[分别为2.1(低剂量)和4.2(高剂量)mmol/kg体重/天],诱导慢性肾外代谢性酸中毒。低剂量组血浆[HCO₃⁻]降低4.5±0.4 mmol/升,高剂量组降低9.1±0.3 mmol/升(P<0.001)。代谢性酸中毒导致肾性低磷血症,这与酸中毒的严重程度密切相关(血浆[PO₄]与血浆[HCO₃⁻];r = 0.721,P<0.001)。两组中1,25-(OH)₂D的代谢清除率和生成率均增加。在高剂量组中,生成率的增加百分比远大于代谢清除率的增加百分比,导致血清1,25-(OH)₂D浓度显著升高。血清1,25-(OH)₂D浓度与血浆[PO₄](r = -0.711,P<0.001)和血浆[HCO₃⁻](r = -0.725,P<0.001)均呈强烈负相关。两组中血浆离子钙浓度均未改变,而高剂量组中完整血清甲状旁腺激素浓度显著降低。总之,代谢性酸中毒通过刺激人体1,25-(OH)₂D的生成率导致血清1,25-(OH)₂D浓度分级升高。生成率增加的原因是酸中毒诱导的低磷血症/细胞内磷酸盐耗竭,这至少部分是由于肾小管磷酸盐重吸收减少所致。在更严重的酸中毒中血清完整甲状旁腺激素水平降低可能是低磷血症和/或血清1,25-(OH)₂D浓度升高的结果。